Research progress on pharmaceutical necessities affecting the cytochrome P450

Abstract

CLC Number:

R968

OUYANG Dong-Sheng, SHUAI Fang-Wen, ZHOU Hong-Hao. Research progress on pharmaceutical necessities affecting the cytochrome P450[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 99-102.

References

[1] 国际药用辅料协会辅料成分指南[S].2009.
[2] 王艳. 新药研究中辅料的使用原则和申报要求[J]. 安徽医药, 2005, 9(10) : 785.
[3] Bittner B, Mountfield RJ.Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters[J]. Curr Opin Drug Discov Dev, 2002, 5(1):59-71.
[4] Liu Y, Huang L, Liu F.Paclitaxel nanocrystals for overcoming multidrug resistance in cancer[J]. Mol Pharma, 2010, 7(3):863-869.
[5] Buggins TR, Dickinson PA, Taylor G.The effects of pharmaceutical excipients on drug disposition[J]. Adv Drug Deliv Rev, 2007, 59(15):1482-1503.
[6] Goole J, Lindley DJ, Roth W, et al.The effects of excipients on transporter mediated absorption[J]. Int J Pharm, 2010, 393(1/2):17-31.
[7] 周宏灏,主编.新编遗传药理学[M].北京:人民军医出版社, 2011.
[8] Smith NF, Mani S, Schuetz EG,et al.Induction of CYP3A4 by Vinblastine: role of the nuclear receptor NR1I2[J]. Ann Pharmacother, 2010, 44(11):1709-1717.
[9] Shahzadi A, Javed I, Aslam B, et al.Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers[J]. Pak J Pharm Sci, 2011, 24(1):63-68.
[10] Park JY, Kim KA, Kim SL, et al.Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes[J]. Antimicrob Agents Chemother, 2003, 47(11):3464-3469.
[11] Ishikawa M, Yoshii H, Furuta T.Interaction of modified cyclodextrins with cytochrome P-450[J]. Biosci Biotechnol Biochem, 2005, 69(1):246-248.
[12] Zhu S, Huang R, Hong M, et al.Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450[J]. Eur J Pharm Sci, 2009, 37(5):573-580.
[13] Ren X, Mao X, Cao L, et al.Nonionic surfactants are strong inhibitors of cytochrome P450 3A biotransformation activity in vitro and in vivo[J]. Eur J Pharm Sci, 2009, 36(4/5):401-411.
[14] Richard J. Mountfield, Sandrine Senepin, Michael Schleimer, et al. Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450[J]. Int J Pharm, 2000, 211(1/2):89-92.
[15] Ren XH, Si LQ, Cao L,et al.Effect of polyoxylether analogous surfactants on the activity of cytochromes P450 3A in rats in vivo[J]. Acta Phar maceutica Sinica, 2008, 439(50): 528-534.
[16] Ren X, Mao X, Si L, et al.Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration[J]. Eur J Pharm Biopharm, 2008, 70(1):279-288.
[17] Bravo González RC, Huwyler J, Boess F, et al.In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam[J]. Biopharm Drug Dispos, 2004, 25(1): 37-49.
[18] Tompkins L, Lynch C, Haidar S, et al.Effects of commonly used excipients on the expression of CYP3A4 in Colon and liver cells[J]. Pharm Res, 2010, 27(8):1703-1712.
[19] Mudra DR, Borchardt RT.Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism[J]. J Pharm Sci, 2010, 99(2): 1016-1027.
[20] Wandel C, Kim RB, Stein CM.“Inactive” excipients such as cremophor can affect in vivo drug disposition[J]. Clin Pharmacol Ther, 2003, 73(5): 394-396.
[21] Bittner B, González RC, Isel H, et al.Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats[J]. Eur J Pharm Biopharm, 2003, 56(1):143-146.
[22] Bittner B, González RC, Walter I, et al.Impact of solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats[J]. Biopharm Drug Dispos, 2003, 24(4): 173-181.
[23] Lee YS, Kim YW, Kim SG, et al.Impact of poloxamers on kinetics of CYP3A in rat liver microsome[J]. Eur Neuropsychopharmacol, 2012,22(6):431-440.
[24] Johnson BM, Charman WN, Porter CJ.An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine[J]. AAPS PharmSci, 2002, 4(4):E40.
[25] Ren XH, Si LQ, Cao Lei, et al.Effect of two different doses of PEG400 with multiple administration on the activity of cytochrome P450 3As in rat[J]. Chin Hosp Pharm J, 2008, 28(22):1912-1916.